This devastating neurodevelopmental disorder has no currently approved treatments.

The Center for Clinical and Translational Science based at the University of Alabama at Birmingham has been awarded four grants from the National Center for Advancing Translational Science, part of the National Institutes of Health, totaling $82 million over seven years.

A new artificial intelligence center will bring more discovery in the field to UAB.

These effector memory B cells appear poised for a rapid serum antibody response upon secondary challenge one year later, and evidence shows that the cells in this subset differ from all previously described memory B cell subsets.

The UAB projects will investigate was to improve and increase the use of artificial intelligence in biomedical research.

The effort led by UAB is projected to receive $17 million from NIH to support up to four years of patient follow-up.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

CABG is a commonly performed, lifesaving surgery for patients with heart attacks and severe disease of the heart’s blood vessels. Avoiding a surgery like CABG due to fears of COVID-19 has “drastic implications.”

NIH research funding to the UAB School of Medicine has increased by more than $100 million in the past five years, a barometer of the school’s success.

UAB School of Dentistry is offering patients with cavities between teeth a new, less painful option for treatment in a new clinical trial.